Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 11, 2007
Current diagnostic approaches in tumor-induced bone diseaseS Sergieva, G Kirova, A DudovJournal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 7, 2007
Magnetic resonance imaging and its value in the staging of cervical carcinoma - Comparison of magnetic resonance imaging and pathological images with FIGO staging systemG Kirova, K Nedialkov, S SergievaJournal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 20, 2007
Nuclear medicine approaches in the monitoring of thyroid cancer patientsS Sergieva, T Hadjieva, M Doldurova, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 8, 2009
Nature of cervical cancer and other HPV - associated cancersSt Georgieva, V Iordanov, S SergievaUkrainskii Biokhimicheskii Zhurnal (1978)|November 1, 1994
[Antioxidant system of rat erythrocytes under conditions of prolonged intake of honeybee flower pollen load]I A Dudov, N F StarodubAkusherstvo I Ginekologiia|February 8, 2014
[Rare clinical case of inflammatory macromastia in childhood]E Alexandrova, S Sergieva, I Mihailova, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 3, 2007
Bone marrow micrometastases as a prognostic factor in early breast cancer patientsE Alexandrova, S Sergieva, V Nikolova, et al.Akusherstvo I Ginekologiia|March 29, 2000
[Sentinel lymph node biopsy. The possibilities for axial staging in early breast cancer and the results in 187 patients]G Baĭchev, T Deliĭski, S Popovska, et al.Anticancer Research|April 20, 2006
Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trialV F Semiglazov, V V Stepula, A Dudov, et al.Anticancer Research|May 25, 2004
The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trialV F Semiglasov, V V Stepula, A Dudov, et al.Pageof 3